Gyre Therapeutics posts corporate presentation; no material financial or pipeline details provided

GYRE THERAPEUTICS, INC.

Updated corporate presentation posted on company website as of Sept 10, 2025.
Presentation prepared for H.C. Wainwright Global Investment Conference in September 2025.
Filing text and exhibit excerpt do not disclose any new financial data or pipeline milestones.
Company focus remains anti-fibrotic therapeutics for chronic organ diseases.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.